Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis.

Min SH, Phung A, Oh TJ, Han KS, Kim MJ, Kim JM, Lee JH, Park YJ.

J Korean Med Sci. 2015 Oct;30(10):1531-4. doi: 10.3346/jkms.2015.30.10.1531. Epub 2015 Sep 12.

2.

High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.

Alexander EK, Larsen PR.

J Clin Endocrinol Metab. 2002 Mar;87(3):1073-7.

PMID:
11889166
3.

The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.

Burch HB, Solomon BL, Cooper DS, Ferguson P, Walpert N, Howard R.

J Clin Endocrinol Metab. 2001 Jul;86(7):3016-21.

PMID:
11443161
4.

Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.

Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE.

J Clin Endocrinol Metab. 1993 Apr;76(4):928-32.

PMID:
7682562
5.

Successful treatment of thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis.

Vyas AA, Vyas P, Fillipon NL, Vijayakrishnan R, Trivedi N.

Endocr Pract. 2010 Jul-Aug;16(4):673-6. doi: 10.4158/EP09265.CR. Review.

PMID:
20439250
6.

Pediatric Graves' disease: controversies in management.

Rivkees SA.

Horm Res Paediatr. 2010;74(5):305-11. doi: 10.1159/000320028. Epub 2010 Oct 2. Review.

7.

Evaluation and Management of Children with Thyrotoxicosis.

Leung AKC, Leung AAC.

Recent Pat Endocr Metab Immune Drug Discov. 2017;11(1):22-31. doi: 10.2174/1872214812666180327112540. Review.

PMID:
29589552
8.

Thyrotoxicosis in children: treatment and outcome.

Jaruratanasirikul S, Leethanaporn K, Sriplung H.

J Med Assoc Thai. 2006 Jul;89(7):967-73.

PMID:
16881428
9.

Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.

Cooper DS.

J Clin Endocrinol Metab. 2003 Aug;88(8):3474-81. No abstract available.

PMID:
12915620
10.

Thyrotoxicosis. Results and risks of current therapy.

de los Santos ET, Mazzaferri EL.

Postgrad Med. 1990 Apr;87(5):277-8, 281-6, 291-4. Review.

PMID:
1690882
11.

Refractory thyrotoxicosis induced by iodinated contrast agents treated with therapeutic plasma exchange. A case report.

Pasimeni G, Caroli F, Spriano G, Antonini M, Baldelli R, Appetecchia M.

J Clin Apher. 2008;23(2):92-5. doi: 10.1002/jca.20161.

PMID:
18293390
12.

Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.

Nakazato N, Yoshida K, Mori K, Kiso Y, Sayama N, Tani JI, Nakagawa Y, Ito S.

Thyroid. 1999 Aug;9(8):775-9.

PMID:
10482369
13.

Unusual clinical course of Graves' thyrotoxicosis and concomitant sarcoidosis: case report and review of literature.

Rodriguez MC, Rani D, Faas FH.

Endocr Pract. 2007 Mar-Apr;13(2):159-63. Review.

PMID:
17490930
14.

[Treatment of diffuse toxic goiter with radioactive iodine in combination with prolonged antithyroid therapy].

Khramtsova VIa, Potin VV, Shliakhtina LG.

Probl Endokrinol (Mosk). 1977 Mar-Apr;23(2):48-51. Russian.

PMID:
71726
16.

Differential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.

Sato K, Omi Y, Kodama H, Obara T, Yamazaki K, Yamada E, Seki T, Takano K, Shiga T, Kasanuki H.

Intern Med. 2008;47(8):757-62. Epub 2008 Apr 16.

17.

The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.

Kubota S, Takata K, Arishima T, Ohye H, Nishihara E, Kudo T, Ito M, Fukata S, Amino N, Miyauchi A.

Thyroid. 2008 Jan;18(1):63-6. doi: 10.1089/thy.2007.0164.

PMID:
18302519
18.

Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.

Ward L, Huot C, Lambert R, Deal C, Collu R, Van Vliet G.

Clin Invest Med. 1999 Aug;22(4):132-9.

PMID:
10497711
19.

Role of plasma exchange in autoimmune hyperthyroidism complicated by severe tiamazol-induced cholestatic jaundice.

Miljić D, Stojanović M, Ješić R, Bogadnović G, Popović V.

Transfus Apher Sci. 2013 Oct;49(2):354-6. doi: 10.1016/j.transci.2013.05.007. Epub 2013 Jun 10.

PMID:
23756266
20.

Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.

Andrade VA, Gross JL, Maia AL.

J Clin Endocrinol Metab. 1999 Nov;84(11):4012-6.

PMID:
10566642

Supplemental Content

Support Center